Virothera Ltd, a biotech start-up, is developing discoveries by the founder in targeting advancement of immune cells by human homologues of virus immune modifiers. These aim to solve problems of regulating immune response in vivo leading to new breakthrough immunotherapies to control recurring persistent disease.
The United Kingdom of Great Britain and Northern Ireland
2025